As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...
AZoLifeSciences on MSN6d
New AI Model Helps Predict Future Mutations in SARS-CoV-2 Spike ProteinIt's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...
COVID-19 has continued to alarm public health, and although several therapeutics and vaccines have been developed, the development of effective vaccines or antibodies is challenging due to mutations ...
The latest variant on the rise is LP.8.1. It’s increasing in Australia, making up close to one in five COVID cases in New ...
Analysis - More than five years since COVID was declared a pandemic, we're still facing the regular emergence of new variants ...
The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.
Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...
COVID-19 as a whole is still a major national and international health concern. So far this year, there have been close to 45 ...
Not just IgG4 antibodies that become predominant in the many-jabbed, but also lesser studied IgG2, researchers find. NIH ...
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback